PDIA2 and central nervous system cancer: Subsequently, we used gliomas of differing WHO grades to evaluate the prognostic value of the risk signature in TCGA and CGGA data sets, and found that the prognostic value of the risk signature based on the nine selected PDI gene members was robust in WHO grade II, III or IV gliomas in both TCGA and CGGA data set.